Foundation Medicine

Foundation Medicine, Inc.

Company type	Subsidiary
Headquarters	Cambridge, Massachusetts , United States
Key people	Brian Alexander (CEO)
Products	FoundationOne CDx FoundationOne Liquid FoundationOne Heme Foundation Insights FoundationSmartTrials
Revenue	$152.9 million (2017)[1]
Owners	Roche
Website	foundationmedicine.com

Foundation Medicine, Inc. is an American company based in Cambridge, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.^[2]